Canaccord Genuity Maintains a 'Buy' on Obagi Medical Products (OMPI); View 2012 as Transitional Year
Tweet
Share
E-mailGet Alerts OMPI Hot Sheet
Price: $23.98 --0%
Rating Summary:
0 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
0 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Obagi Medical Products (NASDAQ: OMPI) price target of $22.50.
Analyst, William J. Plovanic, said, "We maintain our rating on Obagi following an in-line quarter. We believe the resolution of the regulatory matter in Texas was positive but a new inquiry by California is concerning. It was noted that a new e-commerce initiative will be enacted in 2012, resulting in charges to the P&L in 2012 with revenue gains not expected until 2013. As a result of these challenges and initiatives, we believe 2012 will be transitional."
For an analyst ratings summary and ratings history on Obagi Medical Products click here. For more ratings news on Obagi Medical Products click here.
Shares of Obagi Medical Products closed at $11.89 yesterday.
Analyst, William J. Plovanic, said, "We maintain our rating on Obagi following an in-line quarter. We believe the resolution of the regulatory matter in Texas was positive but a new inquiry by California is concerning. It was noted that a new e-commerce initiative will be enacted in 2012, resulting in charges to the P&L in 2012 with revenue gains not expected until 2013. As a result of these challenges and initiatives, we believe 2012 will be transitional."
For an analyst ratings summary and ratings history on Obagi Medical Products click here. For more ratings news on Obagi Medical Products click here.
Shares of Obagi Medical Products closed at $11.89 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)
- Ferrovial SA (FER:SM) (FRRVF) Reiterated at Buy by UBS on Winning Bid For Tennessee Project
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
